0001574540-22-000073.txt : 20220303 0001574540-22-000073.hdr.sgml : 20220303 20220303163410 ACCESSION NUMBER: 0001574540-22-000073 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220301 FILED AS OF DATE: 20220303 DATE AS OF CHANGE: 20220303 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Lucey John W. CENTRAL INDEX KEY: 0001581105 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36007 FILM NUMBER: 22709482 MAIL ADDRESS: STREET 1: 309 N. WATER STREET, SUITE 500 CITY: MILWAUKEE STATE: WI ZIP: 53202 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Physicians Realty Trust CENTRAL INDEX KEY: 0001574540 STANDARD INDUSTRIAL CLASSIFICATION: REAL ESTATE INVESTMENT TRUSTS [6798] IRS NUMBER: 462519850 STATE OF INCORPORATION: MD FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 309 N. WATER STREET STREET 2: SUITE 500 CITY: MILWAUKEE STATE: WI ZIP: 53202 BUSINESS PHONE: 414-367-5600 MAIL ADDRESS: STREET 1: 309 N. WATER STREET STREET 2: SUITE 500 CITY: MILWAUKEE STATE: WI ZIP: 53202 4 1 wf-form4_164634319322942.xml FORM 4 X0306 4 2022-03-01 0 0001574540 Physicians Realty Trust DOC 0001581105 Lucey John W. 309 NORTH WATER STREET SUITE 500 MILWAUKEE WI 53202 0 1 0 0 Chief Acctg. & Admin Officer Common shares, $0.01 par value 2022-03-01 4 A 0 14185 0 A 147877 D Common shares, $0.01 par value 2022-03-01 4 F 0 6145 16.37 D 141732 D Common shares, $0.01 par value 400 I Represents shares held by the Reporting Person's Spouse 2022 Performance Based Restricted Share Unit Grant 2022-03-01 4 A 0 21277 0 A Common shares, $0.01 par value 21277.0 21277 D Represents restricted common shares granted under the Issuer's 2013 Equity Incentive Plan (the "Plan"), which will vest on March 1, 2023, subject to the terms of the grant. March 1, 2022 grant of performance share units under the Issuer's Plan, which represent the "target" number of shares underlying the performance share units. The exact number of shares to be issued upon vesting depends upon, among other things, the Issuer's financial performance. Subject to continued service, the shares, if any, will be issued following the performance period end date of December 31, 2024. /s/ Christopher M. Bartoli, attorney-in-fact 2022-03-03